| Study | Period covered | Study type | Age (years) | No.of cases | OR (95 % CI) |
|---|---|---|---|---|---|
| Glioma | |||||
| Takebayashi et al., 2008, [30] Japan [7] | 2000–2004 | Case–control | 30–69 | 322 | 1.22 (0.63–2.37) |
| The INTERPHONE Study Group,2010, [16] 13countries [9] | 2000–2004 | Case–control | 30–69 | 1078 | glioma 0.81 (0.70–0.94) |
| Frei et al.,2011, [11] Danish [10] | 1990–2007 | cohort | ≥30 | 356 | 1.04 (0.85 - 1.26) in men and 1.04 (0.56 -1.95) in women |
| Deltour et al., 2009, [9] 4 countries [11] | 1974–2003 | cohort | 20–79 | 5390 | 1.05 (0.98-1.08) among men and 1.02 (1.01-1.05) among women |
| Schüz (b) et al., 2006, [26, 27] Germany [12] | 2000–2003 | Case–control | 30–69 | 257 | 0.98 (0.74-1.29) ≥10 years, 2.20, (0.94-5.11) |
| Carlberg et al., 2014, [8] Sweden [17] | 1997–2003 and 2007–2009 | case-case analyses | 18–75 | 1678 |
>20 years 1.7 (1.2–2.3); astrocytoma grade IV Mobile phone use 2.0 (1.4-2.9); cordless phone use 3.4 (1.04-11) |
| Mild et al.,2007, [23] Sweden [18] | 1997–2003 | Case–control | 18–75 | 905 | >10 years, grade I-II 1.6 (0.6-4.1) grade III-IV 2.7 (1.8-4.2) |
| Benson et al., 2013, [2] UK [23] | 1999–2005 and again in 2009 | cohort | middle-aged women | 571 | 0.78, (0.55–1.10), |
| Cardis et al., 2011, [5] five interphone countries [24] | 2000–2004 | Case–control | 30–59 | 553 | 0.93 (0.73 to 1.18) |
| Meningioma | |||||
| Takebayashi et al., 2008, [30] Japan [7] | 2000–2004 | Case–control | 30–69 | 322 | 0.70 (0.42–1.16) |
| The INTERPHONE Study Group,2010, [16] 13 countries [9] | 2000–2004 | Case–control | 30–69 | 1147 | 0.79; (0.68–0.91) |
| Frei et al.,2011, [11] Danish [10] | 1990–2007 | cohort | ≥30 | 80 | ≥10 years, 0.90 (0.57 to 1.42) in men and 0.93 (0.46- 1.87) in women |
| Deltour et al., 2009, [9] 4 countries [11] | 1974–2003 | cohort | 20–79 | 3175 | 1.08 (0.96-1.13) among men, and 1.38 (1.32-1.44) among women |
| Schüz (b) et al., 2006, [26, 27] Germany [12] | 2000–2003 | Case–control | 30–69 | 381 | 0.84 (0.62-1.13) ≥10 years, 1.09 (0.35-3.37) |
| Benson et al., 2013, [2] UK [23] | 1999–2005 and again in 2009. | cohort | middle-aged women | 251 | 0.78, (0.55–1.10) |
| Cardis et al., 2011, [5] five interphone countries [24] | 2000–2004 | Case–control | 30–59 | 676 | 0.80 (0.66 to 0.96) |
| Mild et al.,2007, [23] Sweden [18] | 1997–2003 | Case–control | 18–75 | 759 | 1.3, (0.5-3.2) |
| Acoustic Neuroma | |||||
| Benson et al., 2013, [2] UK [23] | 1999–2005 and again in 2009 | cohort | middle-aged women | 96 | 2.46 (1.07–5.64) |
| Pituitary adenoma | |||||
| Takebayashi et al., 2008, [30] Japan [7] | 2000–2004 | Case–control | 30–69 | 110 | 0.90 (0.50–1.61) |